Fuchs (FPE3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Sales increased 2% year-over-year to €1,804 million in H1, driven by organic and external growth, despite challenging market conditions and weak industrial demand in Europe.
EBIT declined 4% year-over-year to €209 million due to inflationary cost increases, unfavorable product mix in the Americas, and one-off pre-investments.
Free cash flow before acquisitions improved to €81 million, up from €69 million last year, mainly due to net working capital reduction.
Measures have been initiated to support H2 earnings, with the full-year outlook revised downward to reflect current conditions.
Subdued demand from key customer groups and geopolitical tensions contributed to a challenging environment.
Financial highlights
Gross profit increased to €626 million, with gross margin improving to 34.7% from 34.4% year-over-year.
EBIT margin decreased to 11.6% from 12.4% in the prior-year period.
Other function costs rose 7% due to acquisitions, one-time startup costs, and inflation-driven wage adjustments.
Free cash flow before acquisitions is expected to reach around €260 million for the full year.
Net liquidity at -€59 million due to dividend payments and acquisitions.
Outlook and guidance
Full-year sales revenues and EBIT are expected at previous year's levels (~€3,525 million sales, ~€434 million EBIT), revised down from prior guidance.
Free cash flow before acquisitions guidance unchanged at around €260 million.
No significant market recovery is expected for the rest of 2025; guidance assumes a weak macroeconomic environment.
EBIT for H2 is expected to be slightly above last year's level, supported by cost-saving initiatives.
Outlook reflects ongoing market challenges, higher personnel and digitalization costs, and uncertainty from geopolitical and raw material price developments.
Latest events from Fuchs
- Record 2025 results and strong 2026 outlook, with growth tempered by rising uncertainties.FPE3
Q4 202520 Mar 2026 - 2025 saw resilient growth, strong cash flow, and ongoing strategic investment in innovation.FPE3
Investor presentation20 Mar 2026 - Record EBIT, 10% EPS growth, and a 23rd dividend increase highlight strong 2024 results.FPE3
Q4 20243 Feb 2026 - EBIT up 9% to €218M, margin at 12.4%, sales down 3%, outlook confirmed, LUBCON acquired.FPE3
Q2 20242 Feb 2026 - EBIT up 7% to €334M, margin at 12.5%, guidance confirmed, and LUBCON acquired.FPE3
Q3 202417 Jan 2026 - Accelerating growth and sustainability, targeting €500 mn EBIT by 2025 and net zero by 2050.FPE3
CMD 202411 Jan 2026 - Q1 2025 saw 5% sales growth and stable EBIT, led by Asia-Pacific gains.FPE3
Q1 202524 Dec 2025 - Sales up 1% to €2.7bn, EBIT down 2%, full-year outlook confirmed amid economic headwinds.FPE3
Q3 20253 Nov 2025